Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Pune, India, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Point-of-care testing (POCT) is essential for the rapid detection of analytes near to the patient, which facilitates in disease diagnosis, monitoring,...
-
New Clinical Data Support Use of Lesion-Specific FFRCT for Diagnosis and Treatment of Patients With Coronary Artery Disease
-
Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The "Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type (Flow Cytometry, Hematology), By End-use (Operating Room, Emergency...
-
PERSBERICHT 20 oktober 2023, 7:00 CEST Vier abstracts, die uitstekende resultaten voor Idylla™ tonen, worden gepresenteerd op het European Society of Molecular Oncology (ESMO) congres Mechelen,...
-
PRESS RELEASE 20 October 2023, 07:00 CEST Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO) Mechelen, Belgium, 20 October 2023 –...
-
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- In a world where breast cancer awareness is more critical than ever, a groundbreaking research report, titled "Europe Breast Cancer Screening Market, Size,...
-
Wilmington, Delaware, United States, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global consumer genomics market was estimated to have acquired US$ 2.4 billion in 2021....
-
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "Neurological Diagnostic and Monitoring Equipment - Global Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ...
-
PERSBERICHT 16 oktober 2023, 7:00 CEST Biocartis steunt Borstkankermaand met lancering van een borstkankerportfolio Mechelen, België, 16 oktober 2023 - Biocartis Group NV (de 'Vennootschap' of...
-
PRESS RELEASE 16 October 2023, 7:00 CEST Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio Mechelen, Belgium, 16 October 2023 – Biocartis Group NV (the ‘Company’...